Last reviewed · How we verify

NCT05584943

Kinetics of cEVs Over the 24-hour Dosing Interval After Low-dose Aspirin Administration

Completed Last updated 18 October 2022
What this trial tests

trial in Cardiovascular Diseases in 93 participants. Completed in 31 December 2017.

Timeline
21 September 2015
Primary endpoint
9 May 2017
31 December 2017

Quick facts

Lead sponsorG. d'Annunzio University
StatusCompleted
Study typeOBSERVATIONAL
Enrollment93
Start date21 September 2015
Primary completion9 May 2017
Estimated completion31 December 2017

Conditions studied

Sponsor

G. d'Annunzio University

Who can join

Eligibility, any sex, with Cardiovascular Diseases or Vesicle. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Extracellular vesicles (EVs) are small vesicles deriving from all cell types during cell activation, involved in transcellular communication, and regarded as predictors of vascular damage and of cardiovascular events. The investigators will test the hypothesis that, in patients on chronic low-dose aspirin treatment for cardiovascular prevention, aspirin may affect the release of EVs within the 24 hours interval.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other recruiting trials for Cardiovascular Diseases

Currently open trials in the same condition.

Other G. d'Annunzio University trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05584943.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing